Brief: OncBioMune announces term sheet to acquire Norepinefrine from Teva Pharmaceuticals in Mexico
20/03/2017 14:08
March 20 (Reuters) - OncBioMune Pharmaceuticals Inc
OBMP.PK :
* OncBioMune announces term sheet to acquire Norepinefrine
from Teva Pharmaceuticals in Mexico
* Term sheet sets forth guidelines for co to acquire
sanitary registration, intellectual property rights of
Norepinefrine
* Norepinefrine is currently owned by Teva
Source text for Eikon: ID:nMKWLqFWza
Further company coverage: OBMP.PK TEVA.TA
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Theralink Technologies
See all newsBrief: IMAC Holdings - Theralink Will Merge With Newly-Formed Unit Of IMAC In A Stock-For-Stock Reverse Merger Transaction
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say (updated)
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say
Brief: Theralink Technologies Appoints Faith Zaslavsky As President, COO
Brief: Theralink Technologies Appoints Mattia Cremona As Director Of Its Biopharma Laboratory